Completed

NCT Number: NCT06548282

Efficacy of Acceptance and Commitment Therapy for the Management of Quality of Life in Patients Post Myocardial Infarction

The present study aims to investigate the efficacy of acceptance and commitment therapy for the management of quality of life in patients post-myocardial infarction

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Psychological Distress Behavior Health Behavior Medication Adherence Patient Acceptance of Health Care Patient Compliance Quality of Life Treatment Adherence and Compliance Type D Personality

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Armed Forces Institute of Cardiology, Rawalpindi, Punjab Province, Pakistan

About this study

The current quantitative study is carried out in two steps. A cross-sectional survey assesses quality of life and associated factors during the first step. A randomized controlled trial will be done during the second step where patients with myocardial infarction who are identified with type D personality characteristics, psychological distress, low level of medication adherence, low social support, low quality of life, low acceptance and psychological flexibility will be randomly assigned to two groups i.e. waitlist control group and intervention group. The acceptance and commitment therapy would be implemented on participants in the interventional group. As the control group is the waitlist control group; initially no intervention will be given to participants in the control group but the intervention will be given to the control group participants once the study is completed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

First-time diagnosed, non-hospitalized patients with myocardial infarction (MI).
Patients attending follow-up visits at the hospital.
Patients experiencing distress.
Patients exhibiting features of Type D personality.
Patients reporting low levels of:

Quality of Life (QoL)
Medication adherence
Social support
Acceptance
Psychological flexibility
Patients aged 18 years and above.
Both genders.
Patients who can understand Urdu.
Patients who can provide informed consent.

Exclusion criteria

Hospitalized patients with myocardial infarction (MI).
Patients with myocardial infarction (MI) and other chronic co-morbid diseases, such as:

Cancer
Cognitive deficits
Chronic psychological disorders
Patients with silent myocardial infarction.
Patients younger than 18 years.

Treatment and study plan

Acceptance and Commitment Therapy

Other

Introduction: Build rapport and complete pre-assessment questionnaires.

First Session:

Introduce therapist, ACT principles, and MI complications. Provide psychoeducation and assign homework.

Second Session:

Review feedback and encourage change. Assign homework.

Third Session:

Discuss acceptance and coping strategies. Assign homework.

Fourth Session:

Discuss cognitive diffusion and unhelpful thoughts. Assign homework.

Fifth Session:

Explore self-concept and mindfulness. Assign homework.

Sixth Session:

Identify and elaborate on values. Assign homework.

Seventh Session:

Discuss values, goals, and barriers. Assign homework.

Eighth Session:

Discuss commitment to action and relapse prevention. Administer post-test and express gratitude.

Primary outcomes

World Health Organization Quality of Life Scale Urdu Version

Time frame: 3 months

It has 26 items and four domains: physical health (7 items), psychological health (6 items), social relationships (3 items), and environmental health (8 items); it also contains quality of life and general health items. The minimum value is 26 and the maximum value is 130. Higher scores on the scale indicate higher quality of life and low scores indicate low quality of life.

Sponsors and collaborators

Lead sponsor

Fatima Jinnah Women University

Other

Registry information

Important dates

Study start: 2024
Primary completion: 2024
Study completion: 2024
First posted: Aug 12, 2024
Registry last updated: Mar 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed